Metraipolis › archive › dc_88bc78c848ce

Robust POMDP Framework for Lung Cancer Screening Problems — arXiv:2609.12007

Source
arXiv (en)
Original
https://arxiv.org/abs/2609.12007
License (as archived)
CC0-1.0
Archived
2026-10-16T03:44:02.149Z
SHA-256 of the archived text
a7ca0b14853b99f2ac8e085c5533904777766afef0cbdf383716db92552b32db
Stable URL of this page
https://metraipolis.com/documento/dc_88bc78c848ce

How to cite

Robust POMDP Framework for Lung Cancer Screening Problems — arXiv:2609.12007 — arXiv (en), https://arxiv.org/abs/2609.12007 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_88bc78c848ce (Metraipolis archive dc_88bc78c848ce, sha256 a7ca0b14853b99f2ac8e085c5533904777766afef0cbdf383716db92552b32db)
BibTeX
@misc{dc88bc78c848ce,
  title = {Robust POMDP Framework for Lung Cancer Screening Problems — arXiv:2609.12007},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2609.12007},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_88bc78c848ce; sha256 a7ca0b14853b99f2ac8e085c5533904777766afef0cbdf383716db92552b32db},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2609.12007. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Lung cancer remains a leading cause of cancer mortality because many cases are diagnosed at advanced stages. Low-dose computed tomography (LDCT) screening can reduce mortality through earlier detection. Partially observable Markov decision process (POMDP) models can personalize screening by maintaining a belief over an individual's latent cancer state. However, cancer-state transition probabilities are often generated from clinical simulations and are subject to estimation error and model misspecification. We propose a robust POMDP framework using $\ell_1$-norm ambiguity sets around the nominal transition probability. The model optimizes screening decisions against the worst-case transition probability while keeping other components fixed at nominal values. Building on the piecewise-linear and convex structure of the robust value function, we adapt point-based value iteration to compute robust screening policies. We evaluate the policies using out-of-sample simulations that perturb selected cancer-progression parameters and compare them with the nominal ENGAGE policy for representative female and male heavy-smoker cohorts at age 50. Robust POMDP policies generally outperform nominal ENGAGE in mean out-of-sample quality-adjusted life-years (QALYs), with the best performance at a moderate ambiguity radius within the tested grid. Clinical analysis shows that the robust policy reduces lung cancer deaths (LCDs) in all evaluated settings for the female cohort and in most settings for the male cohort, with additional false positives (FPs). Screening-schedule analysis shows that the robust policy recommends more LDCT screens and detects more early-stage lung cancers. These findings show that incorporating transition-model uncertainty into data-driven screening models can improve out-of-sample reliability and provide more robust decision support when clinical simulation inputs are misspecified.

Tema degli esploratori: statistica e scienza dei dati (retro-catalogo arXiv: annunci del 2026-09-14 in stat.AP).
Categorie arXiv: Quantitative Methods (q-bio.QM) ; Optimization and Control (math.OC); Applications (stat.AP).
Pagina del lavoro: https://arxiv.org/abs/2609.12007 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-16T03:15:08.021Z dalla pagina https://arxiv.org/catchup/stat.AP/2026-09-14?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).